USD984882S1 - Unit dose container - Google Patents

Unit dose container Download PDF

Info

Publication number
USD984882S1
USD984882S1 US29/784,852 US202129784852F USD984882S US D984882 S1 USD984882 S1 US D984882S1 US 202129784852 F US202129784852 F US 202129784852F US D984882 S USD984882 S US D984882S
Authority
US
United States
Prior art keywords
unit dose
dose container
view
container
ornamental design
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/784,852
Inventor
Nuo Wang
Shaohui LIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brillian Pharma LLC
Original Assignee
Brillian Pharma LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brillian Pharma LLC filed Critical Brillian Pharma LLC
Assigned to Brillian Pharma LLC reassignment Brillian Pharma LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LIN, Shaohui, WANG, Nuo
Application granted granted Critical
Publication of USD984882S1 publication Critical patent/USD984882S1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/18—Arrangements for indicating condition of container contents, e.g. sterile condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00—General characteristics or adaptations
    • A61J2200/70—Device provided with specific sensor or indicating means
    • A61J2200/76—Device provided with specific sensor or indicating means for fluid level

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Description

FIG. 1 is a perspective view of a first embodiment of a unit dose container showing the new design;
FIG. 2 is a front view of the first embodiment;
FIG. 3 is a rear view of the first embodiment;
FIG. 4 is a right view of the first embodiment;
FIG. 5 is a left view of the first embodiment;
FIG. 6 is a top view of the first embodiment;
FIG. 7 is a bottom view of the first embodiment; and
FIG. 8 is a cross-sectional view of the first embodiment taken along axis 8-8 of FIG. 6 .
FIG. 9 is a perspective view of a second embodiment of the unit dose container showing the new design;
FIG. 10 is a front view of the second embodiment;
FIG. 11 is a rear view of the second embodiment;
FIG. 12 is a right view of the second embodiment;
FIG. 13 is a left view of the second embodiment;
FIG. 14 is a top view of the second embodiment;
FIG. 15 is a bottom view of the second embodiment; and,
FIG. 16 is a cross-sectional view of the second embodiment taken along axis 16-16 of FIG. 14 .
The broken lines are show for the purpose of illustrating parts of the article that form no part of the claimed design.

Claims (1)

    CLAIM
  1. The ornamental design for a unit dose container, as shown and described.
US29/784,852 2019-10-28 2021-05-21 Unit dose container Active USD984882S1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962926777P 2019-10-28 2019-10-28
PCT/US2020/055962 WO2021086635A1 (en) 2019-10-28 2020-10-16 Pharmaceutical unit dose systems for oral dry solution and suspension

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2020/055962 Continuation WO2021086635A1 (en) 2019-10-28 2020-10-16 Pharmaceutical unit dose systems for oral dry solution and suspension

Publications (1)

Publication Number Publication Date
USD984882S1 true USD984882S1 (en) 2023-05-02

Family

ID=75716209

Family Applications (2)

Application Number Title Priority Date Filing Date
US17/618,033 Pending US20220257469A1 (en) 2019-10-28 2020-10-16 Pharmaceutical unit dose systems for oral dry solution and suspension
US29/784,852 Active USD984882S1 (en) 2019-10-28 2021-05-21 Unit dose container

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US17/618,033 Pending US20220257469A1 (en) 2019-10-28 2020-10-16 Pharmaceutical unit dose systems for oral dry solution and suspension

Country Status (5)

Country Link
US (2) US20220257469A1 (en)
EP (1) EP4051285A4 (en)
JP (1) JP2023500472A (en)
CN (1) CN113710251A (en)
WO (1) WO2021086635A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1027651S1 (en) * 2020-10-15 2024-05-21 Lian Fa International Dining Business Corporation Spherical coffee packaging container
USD1036987S1 (en) 2022-11-23 2024-07-30 Zuru (Singapore) Pte. Ltd. Blister cup for confectionery

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220257469A1 (en) * 2019-10-28 2022-08-18 Brillian Pharma Inc. Pharmaceutical unit dose systems for oral dry solution and suspension
CN114869845A (en) * 2022-05-07 2022-08-09 江苏大学 Oseltamivir phosphate sustained-release suspension and preparation method thereof

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD474110S1 (en) * 2002-07-30 2003-05-06 Keurig, Incorporated Cup shaped container
USD476735S1 (en) * 2001-11-14 2003-07-01 Alpharma Uspd Inc. Unit dose cup for a liquid pharmaceutical formulations
USD493105S1 (en) * 2002-12-06 2004-07-20 Ilchester Cheese Co., Ltd. Cheese container
USD520185S1 (en) * 2004-08-23 2006-05-02 The Procter & Gamble Company Capsule
USD606405S1 (en) * 2008-05-12 2009-12-22 Silgan Containers Llc Container
USD647398S1 (en) * 2010-09-02 2011-10-25 Keurig Incorporated Beverage cartridge
USD651096S1 (en) * 2010-05-19 2011-12-27 Ucc Ueshima Coffee Co., Ltd. Beverage extraction filter
USD671830S1 (en) * 2011-02-10 2012-12-04 Wells Enterprises, Inc. Container
GB2498449A (en) * 2012-01-10 2013-07-17 Innavisions Ltd Container with Reinforcing Flange
USD691468S1 (en) * 2011-10-26 2013-10-15 Kraft Foods Group Brands Llc Container
USD732386S1 (en) * 2013-03-21 2015-06-23 Conopco, Inc. Capsule
USD823051S1 (en) * 2016-08-04 2018-07-17 Shankar Sharma Pod
USD845771S1 (en) * 2017-11-28 2019-04-16 Chobani Llc Cup for a yogurt product
USD868543S1 (en) * 2016-08-05 2019-12-03 Dart Industries Inc. Covered bowl
USD906801S1 (en) * 2018-03-29 2021-01-05 Chobani Llc Container
KR20210087135A (en) * 2020-01-02 2021-07-12 (주)대광푸드 Container for retort
US20220257469A1 (en) * 2019-10-28 2022-08-18 Brillian Pharma Inc. Pharmaceutical unit dose systems for oral dry solution and suspension

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191276A1 (en) * 1999-11-30 2004-09-30 Cutispharma, Inc. Compositions and kits for compounding pharmaceuticals
SI2049142T2 (en) * 2006-07-26 2016-04-29 Sandoz Ag Caspofungin formulations
EP2481395A1 (en) * 2011-02-01 2012-08-01 Deva Holding Anonim Sirketi Sachet, effervescent tablet and dry syrup of otilonium
EP2717852B1 (en) * 2011-06-08 2019-05-08 LTS LOHMANN Therapie-Systeme AG Edible oral strip or wafer dosage form containing ion exchange resin for taste masking
CN106573037A (en) * 2014-03-14 2017-04-19 库蒂斯制药公司 Composition and method for vancomycin oral liquid

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD476735S1 (en) * 2001-11-14 2003-07-01 Alpharma Uspd Inc. Unit dose cup for a liquid pharmaceutical formulations
USD474110S1 (en) * 2002-07-30 2003-05-06 Keurig, Incorporated Cup shaped container
USD493105S1 (en) * 2002-12-06 2004-07-20 Ilchester Cheese Co., Ltd. Cheese container
USD520185S1 (en) * 2004-08-23 2006-05-02 The Procter & Gamble Company Capsule
USD606405S1 (en) * 2008-05-12 2009-12-22 Silgan Containers Llc Container
USD651096S1 (en) * 2010-05-19 2011-12-27 Ucc Ueshima Coffee Co., Ltd. Beverage extraction filter
USD647398S1 (en) * 2010-09-02 2011-10-25 Keurig Incorporated Beverage cartridge
USD671830S1 (en) * 2011-02-10 2012-12-04 Wells Enterprises, Inc. Container
USD691468S1 (en) * 2011-10-26 2013-10-15 Kraft Foods Group Brands Llc Container
GB2498449A (en) * 2012-01-10 2013-07-17 Innavisions Ltd Container with Reinforcing Flange
USD732386S1 (en) * 2013-03-21 2015-06-23 Conopco, Inc. Capsule
USD823051S1 (en) * 2016-08-04 2018-07-17 Shankar Sharma Pod
USD868543S1 (en) * 2016-08-05 2019-12-03 Dart Industries Inc. Covered bowl
USD845771S1 (en) * 2017-11-28 2019-04-16 Chobani Llc Cup for a yogurt product
USD906801S1 (en) * 2018-03-29 2021-01-05 Chobani Llc Container
US20220257469A1 (en) * 2019-10-28 2022-08-18 Brillian Pharma Inc. Pharmaceutical unit dose systems for oral dry solution and suspension
KR20210087135A (en) * 2020-01-02 2021-07-12 (주)대광푸드 Container for retort

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Glass Serving Bowl on Ebay. Date posted: 08/25/2022. Site visited: 12/09/2022. Available online: https://www.ebay.com/itm/294060227055 (Year: 2022) *
Glass Serving Bowl on Ebay. Date posted: Aug. 25, 2022. Site visited: Dec. 9, 2022. Available online: https://www.ebay.com/itm/294060227055 (Year: 2022). *
Medical Supply Saline Solution. Date first available: 05/22/2019. Site visited: 12/09/2022. Available online: https://www.amazon.com/AMZ-Solution-Irrigation-Injection-Foil-Lidded/dp/B08QJNX8PQ/ref=sr_1_46 (Year: 2019) *
Medical Supply Saline Solution. Date first available: May 22, 2019. Site visited: Dec. 9, 2022. Available online: https://www.amazon.com/AMZ-Solution-Irrigation-Injection-Foil-Lidded/dp/B08QJNX8PQ/ref=sr_1_46 (Year: 2019). *
Nestle Coffee mate Coffee Creamer. Date first available: 11/13/2018. Site visited: 12/09/2022. Available online: https://www.amazon.com/Nestle-Coffee-Creamer-Portions-vanilla/dp/B009FS5TM2 (Year: 2018) *
Nestle Coffee mate Coffee Creamer. Date first available: Nov. 13, 2018. Site visited: Dec. 9, 2022. Available online: https://www.amazon.com/Nestle-Coffee-Creamer-Portions-vanilla/dp/B009FS5TM2 (Year: 2018). *
Velveeta Mac and Cheese Single Serve Cup on YouTube. Date posted: 11/07/2021. Site visited:012/09/2022. Available online: https://www.youtube.com/watch?v=aoyCKmyDRns (Year: 2021) *
Velveeta Mac and Cheese Single Serve Cup on YouTube. Date posted: Nov. 7, 2021. Site visited:Dec. 9, 2022. Available online: https://www.youtube.com/watch?v=aoyCKmyDRns (Year: 2021). *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1027651S1 (en) * 2020-10-15 2024-05-21 Lian Fa International Dining Business Corporation Spherical coffee packaging container
USD1036987S1 (en) 2022-11-23 2024-07-30 Zuru (Singapore) Pte. Ltd. Blister cup for confectionery

Also Published As

Publication number Publication date
WO2021086635A1 (en) 2021-05-06
EP4051285A1 (en) 2022-09-07
EP4051285A4 (en) 2023-12-06
JP2023500472A (en) 2023-01-06
US20220257469A1 (en) 2022-08-18
CN113710251A (en) 2021-11-26

Similar Documents

Publication Publication Date Title
USD997650S1 (en) Container
USD923394S1 (en) Bottle cap
USD966095S1 (en) Container
USD944649S1 (en) Bottle
USD933484S1 (en) Bottle
USD984882S1 (en) Unit dose container
USD980571S1 (en) Coating material container
USD934679S1 (en) Absorbent article package
USD885145S1 (en) Food container
USD1002364S1 (en) Packaging container
USD925373S1 (en) Bottle
USD888567S1 (en) Container
USD939975S1 (en) Thermo-hygrometer
USD944647S1 (en) Bottle
USD1017422S1 (en) Container
USD851958S1 (en) Basket
USD962075S1 (en) Container
USD912530S1 (en) Container
USD892547S1 (en) Bottle lid
USD899921S1 (en) Container
USD897212S1 (en) Dispenser
USD948345S1 (en) Bottle
USD948344S1 (en) Bottle
USD890252S1 (en) Synthesizer
USD944648S1 (en) Bottle

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY